Brief: Deciphera Pharmaceuticals Q4 Basic EPS USD -0.54 Vs. IBES Estimate USD -0.58
Feb 06 (Reuters) - Deciphera Pharmaceuticals Q4 operating income USD -51.237 million vs. IBES estimate USD -53.8 million. * Q4 net income USD -47.19 million vs. IBES estimate USD -50.4 million * Q4 product revenues USD 46.712 million vs. IBES estimate USD 45.9 million * Q4 operating expenses USD 99.532 million
Recent news on Deciphera Pharmaceuticals
See all newsBrief: Deciphera Pharmaceuticals Announces Oral Presentation Of Results From Phase 3 Study of Vimseltinib In Patients With Tenosynovial Giant Cell Tumor
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
Deals of the day-Mergers and acquisitions